CELLINK is the first Bioink company in the world and a world leader and expert in 3D-Bioprinting. The company develops bioprinting technology that enable scientists to 3D-Bioprint human tissues and organs and new biomaterial solutions for researchers worldwide. This can be utilized in a wide range of targets in the biotech field, including tissue engineering, cancer research, disease models and drug testing. Our goal and focus are to ensure that researchers are provided with the tools they need to revolutionize the medical industry through 3D-Bioprinting.
